About Ross Leimberg
Ross Leimberg is a chief operating officer and director at Cantai Therapeutics.
Ross Leimberg first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ross Leimberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ross Leimberg works with at each company, as listed on that company's latest Form D.
Cantai Therapeutics, Inc. · Form D, Jan 21, 2026
EA
Errik Anderson
Executive officer
GV
Getta Vemuri
Executive officer and director